KeyBank National Association’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

KeyBank National Association’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,369	Closed	-$128K	–	1275
2015 Q1	$128K	Sell	1,369 -66	-5%	-$5.62K	﹤0.01%	1185
2014 Q4	$128K	Sell	1,435 -1,180	-45%	-$86K	﹤0.01%	1193
2014 Q3	$181K	Hold	2,615	–	–	﹤0.01%	1180
2014 Q2	$150K	Hold	2,615	–	–	﹤0.01%	1232
2014 Q1	$104K	Hold	2,615	–	–	﹤0.01%	1249
2013 Q4	$110K	Hold	2,615	–	–	﹤0.01%	1245
2013 Q3	$78K	Hold	2,615	–	–	﹤0.01%	1226
2013 Q2	$139K	Buy	+2,615	New	+$115K	﹤0.01%	1274

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

KeyBank National Association's MACK Position: Q2 2015 in Review

KeyBank National Association sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2015, closing a stake of 1,369 shares — an estimated $128K sold.

KeyBank National Association first reported a position in MACK in Q2 2013 and held it in 8 quarters. The position peaked at $181K in Q3 2014. 150 funds tracked by Wall St. Rank hold MACK as of Q2 2015.

KeyBank National Association reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
KeyBank National Association sold 1,369 Merrimack Pharmaceuticals, Inc. shares in Q2 2015, an estimated $128K.
KeyBank National Association first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 8 quarters.
KeyBank National Association's Merrimack Pharmaceuticals, Inc. position peaked at $181K in Q3 2014.
150 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2015.

Based on KeyBank National Association's 13F filing for Q2 2015, filed 10 Aug 2015.